CD90(low) MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer

Both anti-tumoral and pro-tumoral effects of mesenchymal stem cells (MSCs) in preclinical treatment of ovarian cancer have been controversially demonstrated. In this study, we profiled the phenotypes of mouse compact bone-derived MSCs (CB-MSCs) and bone marrow-derived MSCs (BM-MSCs) and found that C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yang, Li, Binghao, Li, Tao, Liu, Wei, Ran, Chongzhao, Penson, Richard T., Poznansky, Mark C., Du, Yanan, Chen, Huabiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633895/
https://www.ncbi.nlm.nih.gov/pubmed/31320999
http://dx.doi.org/10.18632/oncotarget.27065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633895/
https://www.ncbi.nlm.nih.gov/pubmed/31320999
http://dx.doi.org/10.18632/oncotarget.27065

Ejemplares similares